• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARDIOVASCULAR SYSTEMS INC. STEALTH 360 ORBITAL ATHERECTOMY SYSTEM; PERIPHERAL ATHERECTOMY DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARDIOVASCULAR SYSTEMS INC. STEALTH 360 ORBITAL ATHERECTOMY SYSTEM; PERIPHERAL ATHERECTOMY DEVICE Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Arrhythmia (1721); Embolism/Embolus (4438); Swelling/ Edema (4577); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 01/10/2024
Event Type  Injury  
Manufacturer Narrative
H6 health effect - clinical code 4581: slow/no flow h6 investigation conclusion code 22: the diamondback 360® coronary orbital atherectomy system instructions for use manual states that distal embolization and slow flow or no reflow phenomenon are potential adverse events that may occur and/or require intervention with use of the system.The device history record for the reported oad could not be reviewed as the lot number was not provided.If the lot number is provided, a dhr review will be performed.The results of the investigation are inconclusive since the reported device was not returned for analysis.Based on the information received, the cause of the reported event could not be conclusively determined.Csi id: (b)(4).
 
Event Description
During treatment of a moderately calcified lesion about 150mm in length, in the left superficial femoral artery (sfa) via right common femoral access and left pedal access, the stealth 360 orbital atherectomy device (oad) was spun initially at low speed, medium speed and then high speed.Angioplasty was done and a stent was placed in the sfa.The physician believed that during the procedure, the plaque embolized down to the foot causing slow flow.A non-csi oad was used to treat embolization on the following day ((b)(6)2024).During follow-up ((b)(5)2024), the patient had a strong pulse and warm foot.It was noted that the edema was better.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STEALTH 360 ORBITAL ATHERECTOMY SYSTEM
Type of Device
PERIPHERAL ATHERECTOMY DEVICE
Manufacturer (Section D)
CARDIOVASCULAR SYSTEMS INC.
1225 old highway 8 nw
st. paul MN 55112
Manufacturer (Section G)
CARDIOVASCULAR SYSTEMS INC.
1225 old highway 8 nw
st. paul
Manufacturer Contact
keerthi bangalore ramanath
1225 old highway 8 nw
st. paul 55112
MDR Report Key18677593
MDR Text Key335024517
Report Number3004742232-2024-00092
Device Sequence Number1
Product Code MCW
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K190634
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 02/08/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/09/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/16/2024
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age58 YR
Patient SexMale
Patient Weight78 KG
-
-